[1]
Dr Sandeep Bhete et al. 2026. EFFICACY AND SAFETY OF PCSK9 INHIBITORS IN REDUCING MAJOR ADVERSE CARDIOVASCULAR EVENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. Journal of Population Therapeutics and Clinical Pharmacology. 33, 1 (Jan. 2026), 137–145. DOI:https://doi.org/10.53555/j12rts45.